
Read More
CuraTeQ Biologics receives approval for Biosimilar Zefylti from the UK’s MH...
The company has a market cap of over Rs 70,000 crore and the stock is up by 24.3 per cent from its 5...

The company has a market cap of over Rs 70,000 crore and the stock is up by 24.3 per cent from its 5...

The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-...

The biosimilars division alongside niche product development represents Aurobindo Pharma's main focu...